Stem Cells, Vol 13, 281-288, Copyright © 1995 by AlphaMed Press

ORIGINAL ARTICLES

Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow

C De Bruyn, A Delforge, D Bron, M Bernier, M Massy, P Ley, D de Hemptinne and P Stryckmans
Service de Medecine Interne et Laboratoire d'Investigation Clinique Henri Tagnon, Institut Jules Bordet, Brussels, Belgium.

Human umbilical cord blood (UCB) cells are currently considered as a potential source of stem cells for transplantation. However, it remains unclear whether a single collection of UCB contains enough progenitors to allow a successful engraftment in adult patients. We were interested in the comparison of the frequency of primitive progenitors in UCB and in human bone marrow (BM). UCB and BM CD34+ cells were purified and compared for their coexpression of CD38, CD33 and HLA-DR. UCB and BM mononuclear fractions were enriched in CD34+ cells using the CEPRATE LC system (CellPro, Bothell, WA). Double-labeling analysis with a flow cytometer showed that 67.9 +/- 7.2% of UCB CD34+ cells are CD38-, while in BM only 10.9 +/- 4.9% of CD34+ are CD38- (p < 0.001). Moreover, our study indicated that a significantly higher percentage of UCB CD34+ is CD33- (97.1 +/- 1.2%) compared to BM (61.8 +/- 8.6%) (p = 0.013). The coexpression of CD34 with HLA-DR was not significantly different in UCB and in BM (respectively, 86.3 +/- 2.7% and 92.7 +/- 5.1%). On the other hand, in vitro assays showed that the number of multipotent (colony- forming units granulocyte-erythroid-macrophage-megakaryocyte [CFU- GEMM]), myeloid (colony-forming units granulocyte-macrophage [CFU-GM]) and erythroid (burst-forming units-erythroid [BFU-E]) progenitors is lower in the CD34+ population from UCB than from BM. In conclusion, in UCB, we have found a significantly higher percentage of CD34+ cells which lacked the expression of CD38 and CD33 antigens suggesting that UCB contains higher proportions of immature progenitor cells (CD34+CD38- and CD34+CD33-) than BM. It seems thus likely that fewer UCB CD34+ cells than BM CD34+ cells would be required for sustained engraftment following transplantation.

This article has been cited by other articles:

				E. J. Tsai, H. L. Malech, M. R. Kirby, A. P. Hsu, N. E. Seidel, C. D. Porada, E. D. Zanjani, D. M. Bodine, and J. M. Puck Retroviral transduction of IL2RG into CD34+ cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras Blood, June 17, 2002; 100(1): 72 - 79. [Abstract] [Full Text] [PDF]

				R. W. Storms, M. A. Goodell, A. Fisher, R. C. Mulligan, and C. Smith Hoechst dye efflux reveals a novel CD7+CD34- lymphoid progenitor in human umbilical cord blood Blood, September 15, 2000; 96(6): 2125 - 2133. [Abstract] [Full Text] [PDF]

				T. M. Opie, L. E. Shields, and R. G. Andrews Cell-Surface Antigen Expression in Early and Term Gestation Fetal Hematopoietic Progenitor Cells Stem Cells, September 1, 1998; 16(5): 343 - 348. [Abstract] [Full Text]

				L.-X. Cao, M.-C. Le Bousse-Kerdiles, D. Clay, S. Oshevski, C. Jasmin, and P. Krief Implication of a New Molecule IK in CD34+ Hematopoietic Progenitor Cell Proliferation and Differentiation Blood, May 15, 1997; 89(10): 3615 - 3623. [Abstract] [Full Text] [PDF]

				J. E.J. Rasko, E. O'Flaherty, and C. G. Begley Mpl Ligand (MGDF) Alone and in Combination with Stem Cell Factor (SCF) Promotes Proliferation and Survival of Human Megakaryocyte, Erythroid and Granulocyte/Macrophage Progenitors Stem Cells, January 1, 1997; 15(1): 33 - 42. [Abstract] [Full Text]